Chronic constipation: modern view on the problem. A review
DOI:
https://doi.org/10.30978/GS-2021-1-67Keywords:
slow transit constipation, laxatives, total colectomy, ileorectal anastomosisAbstract
Chronic constipation is a frequently diagnosed heterogeneous pathology that significantly impairs the quality of life in all population groups and its frequency increases with age. It commonly affects up to 10 — 15 % of the population. There are numerous classifications of constipation due to a great number of disorders that cause it. The types of constipation are identified based on the etiology or mechanism of its development. Different criteria are used to specify the categorization of constipation, but it is still difficult to find one general classification including all types of constipation. The Rome IV criteria categorize disorders of chronic constipation into four subgroups. The treatment depends on the subtype. The significant increase of constipation cases is observed nowadays. This disorder is facilitated by a sedentary lifestyle, insufficient amount of fiber and fluid in the diet, a wide range of diseases that directly lead to the development of chronic constipation, congenital and acquired pathologies, abnormal intake of laxatives and opioids or a combination of these factors. Despite numerous publications on slow transit constipation, the latter is still the subject of research for many specialists. A lot of recent scientific works have been dedicated to the immunohistochemical studies of interstitial pacemaker cells. The numbers of markers they express were found. Consequently, the investigations of modern scientists are aimed to develop and implement new laboratory methods for determining the indications for surgical treatment depending on a diagnosed disorder of the intestinal neurophysiology. These methods will ensure a differentiated selection of patients for surgical treatment. The step approach to the diagnosis of chronic constipation allows choosing an adequate treatment method in order to improve symptoms, the quality of life, and patient satisfaction. The literature review indicates that surgery still remains the most radical treatment method for patients with slow transit constipation.
References
Allen L, et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. The Lancet Global Health, 2017;5.3:e277-89. doi: 10.1016/S2214-109X(17)30058-X.
Andresen V, Banerji V, Hall G, Lass A, Emmanuel AV. The patient burden of opioid induced constipation: New insights from a large, multinational survey in five European countries. UEG J. 2018;6:1254-66. doi: 10.1177/2050640618786145.
Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998;45(21):727-32.
Attaluri A, Donahoe R, Valestin J, Brown K, Rao SSC. Randomized clinical trial: dried plums (prunes) vs. psyllium for constipation: Randomized clinical trial: dried plums in constipation. Aliment Pharmacol Ther. 2011;33:822-8. doi: 10.1111/j.1365-2036.2011.04594.x.
Attar A, Lémann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999;44(2):226-30. doi: 10.1136/gut.44.2.226.
Aziz Imran, et al. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert review of gastroenterology & hepatology. 2020;14.1:39-46. doi: 10.1080/17474124.2020.1708718.
Bassotti G, de Roberto G, Castellani D, Sediari L, Morelli A. Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol. 2005;11:2691-6. doi: 10.3748/wjg.v11.i18.2691.
Bassotti G, Villanacci V, Maurer CA, et al. The role of glial cells and apoptosis of enteric neurons in the neuropathology of intractable slow transit constipation. Gut. 2006;55:41-6. doi: 10.1136/gut.2005.073197.
Bellini M. Irritable bowel syndrome and chronic constipation: Fact and fiction. World J Gastroenterol. 2015;21:11362. doi: 10.3748/wjg.v21.i40.11362.
Bouchoucha M, Devroede G, Mary F, Bon C, Bejou B, Benamouzig R. Painful or mild pain constipation? A clinically useful alternative to classification as irritable bowel syndrome with constipation versus functional constipation. Dig Dis Sci. 2018;63:1763-73. doi: 10.1007/s10620-018-4995-6.
Brand RA. Sir William Arbuthnot Lane, 1856-1943. Clinical Orthopaedics and Related Research 467.8. 2009:1939-1943. doi: 10.1007/s11999-009-0861-3.
Brenner DM, Fogel R, Dorn SD, et al. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. Am J Gastroenterol. 2018;113(5):735-45. doi: 10.1038/s41395-018-0026-7.
Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001;49:66-72. doi: 10.1136/gut.49.1.66.
Camilleri M, Ford AC, Mawe GM, et al. Chronic constipation. Nat Rev Dis Primers. 2017;3:17095. doi: 10.1038/nrdp.2017.95.
Camilleri M, Piessevaux H, Yiannakou Y, et al. Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials. Dig Dis Sci. 2016;61(8):2357-72. doi: 10.1007/s10620-016-4147-9.
Chan AO, Lam KF, Hui WM, et al. Influence of positive family history on clinical characteristics of functional constipation. Clin Gastroenterol Hepatol. 2007;5:197-200. doi: 10.1016/j.cgh.2006.10.009.
Chapman RW, Stanghellini V, Geraint M, et al. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol. 2013;108(9):1508-15. doi: 10.1038/ajg.2013.197.
Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012;107(11):1702-12. doi: 10.1038/ajg.2012.254.
Chiarelli P, Brown W, McElduff P. Constipation in Australian women: prevalence and associated factors. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:71-8. doi: 10.1007/s001920050073.
Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129(1):86-97. doi: 10.1053/j.gastro.2005.05.015.
Chiarioni G, Whitehead WE, Pezza V, et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657-64. doi: 10.1053/j.gastro.2005.11.014.
Cinca R, Chera D, Gruss HJ, et al. Randomized clinical trial: macrogol/ PEG 350+electrolytes versus prucalopride in the treatment of chronic constipation — a comparison in a controlled environment. Aliment Pharmacol Ther. 2013;37(9):876-86. doi: 10.1111/apt.12278.
Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009;21(Suppl 2):1-8 doi: 10.1111/j.1365-2982.2009.01399.x.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):126-79. doi: 10.1053/j.gastro.2016.02.032.
Farmer AD, Drewes AM, Chiarioni G, et al. Pathophysiology and management of opioid induced constipation: European expert consensus statement. United European Gastroenterol J. 2019;7(1):7-20. doi: 10.1177/2050640618818305.
Farmer AD, Holt CB, Downes TJ, Ruggeri E, Del Vecchio S, De Giorgio R. Pathophysiology, diagnosis, and management of opioid induced constipation. Lancet Gastroenterol Hepatol. 2018;3:203-12. doi: 10.1016/S2468-1253(18)30008-6.
Fitz Harris GP, Garcia-Aguilar J, Parker SC, et al. Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count. Dis Colon Rectum. 2003;46:433-40. doi: 10.1007/s10350-004-6576-3.
Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;1:S2-S26. doi: 10.1038/ajg.2014.187.
Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and metanalysis. Gut. 2011;60:209-18. doi: 10.1136/gut.2010.227132.
Frattini JC, Nogueras JJ. Slow transit constipation: a review of a colonic functional disorder. Clin Colon Rectal Surg. 2008;21:146-52. doi: 10.1055/s-0036-1593436.
Gao R, Tao Y, Zhou C, et al. Exercise therapy in patients with constipation: a systematic review and metanalysis of randomized controlled trials. Scand J Gastroenterol. 2019;54(2):169-77. doi: 10.1080/00365521.2019.1568544.
Gonenne J, Esfandyari T, Camilleri M, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil. 2006;18:911-8. doi: 10.1111/j.1365-2982.2006.00808.x.
Guérin A, Mody R, Fok B, et al. Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Alimentary pharmacology & therapeutics. 2014;40(1):83-92. doi: 10.1111/apt.12789.
Gupta A. Improving the recognition and diagnosis of opioid induced constipation in clinical practice. J Fam Pract. 2015;64(10 Suppl 1). doi: 10.1097/AJP.0000000000000852.
Hsiao KC, Jao SW, Wu CC, Lee TY, Lai HJ, Kang JC. Handassisted laparoscopic total colectomy for slow transit constipation. Int J Colorectal Dis. 2008;23:419-24. doi: 10.1007/s00384-007-0431-7.
Hagiwara N, Tomita R. Pathophysiology of chronic constipation of the slow transit type from the aspect of the type of rectal movements. Hepatogastroenterology. 2008;55:1298-303.
Hajizadeh Maleki B, Tartibian B, Mooren FC, et al. Low-to-moderate intensity aerobic exercise training modulates irritable bowel syndrome through antioxidative and inflammatory mechanisms in women: results of a randomized controlled trial. Cytokine. 2018;102:18-25. doi: 10.1016/j.cyto.2017.12.016.
Hanani M, Fellig Y, Udassin R, Freund HR. Agerelated changes in the morphology of the myenteric plexus of the human colon. Auton Neurosci. 2004; 113:71-8. doi: 10.1016/j.autneu.2004.05.007.
He CL, Burgart L, Wang L, et al. Decreased interstitial cell of cajal volume in patients with slow-transit constipation. Gastroenterology. 2000;118:14-21. doi: 10.1016/s0016-5085(00)70409-4.
Heymen S, Scarlett Y, Jones K, et al. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum. 2007;50(4):428-41. doi: 10.1007/s10350-006-0814-9.
Jamal MM, Adams AB, Jansen JP, et al. A randomized, placebo-controlled trial of lubiprostone for opioid induced constipation in chronic noncancer pain. Am J Gastroenterol. 2015;110(5):725-32. doi: 10.1038/ajg.2015.106.
Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective: Patient perspective on constipation. Aliment Pharmacol Ther. 2007;25:599-608. doi: 10.1111/j.1365-2036.2006.03238.x.
Juul T, Christensen P. Prospective evaluation of transanal irrigation for fecal incontinence and constipation. Tech Coloproctol. 2017;21(5):363-71. doi: 10.1007/s10151-017-1635-7.
Kamm MA, Mueller-Lissner S, Wald A, et al. Oral bisacodyl is effective and well tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol. 2011;9(7):577-83. doi: 10.1016/j.cgh.2011.03.026.
King SK, Sutcliffe JR, Ong SY, et al. Substance P and vasoactive intestinal peptide are reduced in right transverse colon in pediatric slow-transit constipation. Neurogastroenterol Motil. 2010 Aug;22(8):883-92. doi: 10.1016/j.cgh.2011.03.026.
Knowles CH, Grossi U, Chapman M, et al. Surgery for constipation: systematic review and practice recommendations: results I: colonic resection. Colorectal Dis. 2017;19(Suppl 3):17-36. doi: 10.1111/codi.13779.
Knowles CH, Scott M, Lunniss PJ. Outcome of colectomy for slow transit constipation. Ann Surg. 1999;230:627-38. doi: 10.1097/00000658-199911000-00004.
Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-407. doi: 10.1053/j.gastro.2016.02.031.
Lane WA. Chronic constipation and its medical and surgical treatment. British medical journal.1905;1.2309:700. doi: 10.1136/bmj.1.2309.700.
Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011;365(6):527-36. doi: 10.1056/NEJMoa1010863.
Li F, Fu T, Tong WD, et al. Lubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and metanalysis of randomized controlled trials. Mayo Clin Proc. 2016;91(4):456-68. doi: 10.1016/j.mayocp.2016.01.015.
Lim YJ, Rosita J, Chieng JY, Hazizi AS. The prevalence and symptoms characteristic of functional constipation using Rome III diagnostic criteria among tertiary education students. PLoS ONE. 2016;11:e0167243.. doi: 10.1371/journal.pone.0167243
Ludvigsson JF. Epidemiological study of constipation and other gastrointestinal symptoms in 8000 children. Acta Paediatr. 2006;95:573-80. doi: 10.1080/08035250500452621.
Luthra P, Burr NE, Brenner DM, et al. Efficacy of pharmacological therapies for the treatment of opioid induced constipation: systematic review and network metanalysis. Gut. 2018 May 5. Epub ahead of print. doi: 10.1136/gutjnl-2018-316001.
Major, Giles, et al. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging. Neurogastroenterology & Motility 30.9 (2018):e13400. doi: 10.1111/nmo.13400.
Mearin F, Lacy BE, Chang L, et al. Bowel disorders. In: Drossman DA, Chang L, Chey WD, Kellow J, Tack J, Whitehead WE, eds. ROME IV, Functional Gastrointestinal Disorders.-Disorders of gut-brain interactions, 4th ed. Raleigh, NC: The Rome Foundation; 2016. P. 967-1058.
Mueller-Lissner S, Kamm MA, Wald A, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol. 2010;105(4):897-903. doi: 10.1038/ajg.2010.41.
Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011;25:3-18. doi: 10.1016/j.bpg.2010.12.010.
Nakajima A, Seki M, Taniguchi S, et al. Safety and efficacy of elobixibat for chronic constipation: results from a randomized, double-blind, placebo-controlled, phase 3 trial and an open label, single arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(8):537-47. doi: 10.1016/S2468-1253(18)30123-7.
Ostwani W, Dolan J, Elitsur Y. Familial clustering of habitual constipation: a prospective study in children from West Virginia. J Pediatr Gastroenterol Nutr. 2010;50:287-9. doi: 10.1097/MPG.0b013e3181a0a595.
Palsson OS, Whitehead WE, van Tilburg MAL, et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology. 2016;150:1481-91. doi: 10.1053/j.gastro.2016.02.014.
Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol. 2008;8:5. doi: 10.1186/1471-230X-8-5.
Pikarsky AJ, Singh JJ, Weiss EG, Nogueras JJ, Wexner SD. Long-term follow-up of patients undergoing colectomy for colonic inertia. Dis Colon Rectum. 2001;44:179-83. doi: 10.1007/BF02234290.
Pilkington SA, et al. Surgery for constipation: systematic review and practice recommendations: Results V: Sacral Nerve Stimulation. Colorectal Disease, 2017;19:92-100. doi: 10.1111/codi.13780.
Power AM, Talley NJ, Ford AC. Association between constipation and colorectal cancer: systematic review and metanalysis of observational studies. Am J Gastroenterol. 2013;108(6):894-903. quiz 904. doi: 10.1038/ajg.2013.52.
Prather CM. Subtypes of constipation: sorting out the confusion. Rev Gastroenterol Disord. 2004;4(Suppl 2):S11-6.
Probert CJ, Emmett PM, Heaton KW. Intestinal transit time in the population calculated from self-made observations of defecation. J Epidemiol Community Health. 1993;47:331-3. doi: 10.1136/jech.47.4.331.
Quigley EM, Tack J, Chey WD, et al. Randomized clinical trials: linaclotide phase 3 studies in IBS-C — a prespecified further analysis based on European medicines agency-specified endpoints. Aliment Pharmacol Ther. 2013;37(1):49-61. doi: 10.1111/apt.12123.
Rao S, Lembo AJ, Shiff SJ, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol. 2012;107(11):1714-24. quiz p.1725. doi: 10.1038/ajg.2012.255.
Rao SS, Bharucha AE, Chiarioni G, et al. Functional anorectal disorders. Gastroenterology. 2016;150(6):1430-42. doi: 10.1053/j.gastro.2016.02.009.
Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol. 2005;100:1605-15. doi: 10.1111/j.1572-0241.2005.41845.x.
Rao SS, Patcharatrakul T. Diagnosis and treatment of dyssynergic defecation. J Neurogastroenterol Motil. 2016;22(3):423-35. doi: 10.5056/jnm16060.
Rao SSC, Go JT, Valestin J, et al. Home biofeedback for the treatment of dyssynergic defecation: does it improve quality of life and is it cost-effective? Am J Gastroenterol. 2019;114(6):938-44. doi: 10.14309/ajg.0000000000000278.
Schmidt FM, Santos VL. Prevalence of constipation in the general adult population: an integrative review. J Wound Ostomy Continence Nurs. 2014;41:70-6. doi: 10.1097/01.WON.0000438019.21229.b7.
Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23:151-63. doi: 10.5056/jnm16214.
Serra Jordi, et al. European society of neurogastroenterology and motility guidelines on functional constipation in adults. Neurogastroenterology & Motility. 2020;32.2:e13762. doi: 10.1111/nmo.13762.
Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil. 1997;9:143-50. doi: 10.1046/j.1365-2982.1997.d01-46.x.
Sood R, Ford AC. Rome IV criteria for FGIDs — an improvement or more of the same?: Diagnosis. Nat Rev Gastroenterol Hepatol. 2016;13:501-2. doi: 10.1038/nrgastro.2016.110.
Spijkerman M, Tan IL, Kolkman JJ, et al. A large variety of clinical features and concomitant disorders in celiac disease — A cohort study in the Netherlands. Dig Liver Dis. 2016;48(5):499-505. doi: 10.1016/j.dld.2016.01.006.
Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and metanalysis. Am J Gastroenterol. 2011;106(9):1582-1591. quiz 1581, 1592. doi: 10.1038/ajg.2011.164.
Tack J, Müller-Lissner S, Stanghellini V, et al. Diagnosis and treatment of chronic constipation a European perspective: Diagnosis and treatment of chronic constipation. Neurogastroenterol Motil. 2011;23:697-710.. doi: 10.1111/j.1365-2982.2011.01709.x.
Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003;98:1107-1111. doi: 10.1111/j.1572-0241.2003.07465.x.
Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999; 45(Supplement 2):ii43-ii47. doi: 10.1136/gut.45.2008.ii43.
Tomita R, Fujisaki S, Ikeda T, Fukuzawa M. Role of nitric oxide in the colon of patients with slow transit constipation. Dis Colon Rectum. 2002;45:593-600. doi: 10.1007/s10350-004-6251-8.
Tomita R, Tanjoh K, Fujisaki S, Ikeda T, Fukuzawa M. Regulation of the enteric nervous system in the colon of patients with slow transit constipation. Hepatogastroenterology. 2002;49:1540-4. doi: 10.3748/wjg.v9.i9.2065.
Törnblom H, Van Oudenhove L, Sadik R, et al. Colonic transit time and IBS symptoms: what’s the link? Am J Gastroenterol. 2012;107(5):754-60. doi: 10.1038/ajg.2012.5.
Webster C, Dayton M. Results after colectomy for colonic inertia: a sixteen-year experience. Am J Surg. 2001;182:639-44. doi: 10.1016/s0002-9610(01)00820-0
Wedel T, Roblick UJ, Ott V, Eggers R, Schiedeck THK, Krammer HJ, Bruch HP. Oligoneural hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum. 2002;45:54-62. doi: 10.1007/s10350-004-6114-3.
Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459-67. doi: 10.1016/s0002-9610(01)00820-0.
Xin HW, Fang XC, Zhu LM, et al. Diagnosis of functional constipation: Agreement between Rome III and Rome II criteria and evaluation for the practicality: FC diagnosis by Rome III and II criteria. J Digest Dis. 2014;15:314-20.
